earnings call
Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Bristol-Myers Squibb Company (BMY) SEC filings
Bristol-Myers Squibb Company (BMY) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 13.2. The BMY filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Bristol-Myers Squibb Company said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsEvent insights for BMY — what management said, what changed, and why it matters.
No cached SEC filings for BMY yet. When an 8-K lands, this page will list it.
These filings as JSON? API free 100/dayBMY SEC filings FAQ
What events are listed on the BMY SEC page?
Cached event headlines on this Bristol-Myers Squibb Company (BMY) SEC page: "BMY earnings". Events: https://lician.com/sec/bmy
What is BMY's P/E ratio?
Bristol-Myers Squibb Company (BMY) trailing P/E is 13.2 on the latest cached fundamentals snapshot.
What are BMY's latest revenue and net income?
Latest cached Bristol-Myers Squibb Company (BMY) revenue for Dec 31, 2025 was $48.19B. Net income was $7.05B. Statements: https://lician.com/financials/bmy